Literature DB >> 15232129

Homozygosity of the T allele of the 46 C->T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population.

Amparo Santamaría1, José Mateo, Isabel Tirado, Arturo Oliver, Roberto Belvís, Joan Martí-Fábregas, Rosa Felices, José Manuel Soria, Juan Carlos Souto, Jordi Fontcuberta.   

Abstract

BACKGROUND AND
PURPOSE: Ischemic stroke (IS) is a complex disease that involves genetic and environmental factors. In a family-based study (the Genetic Analysis of Idiopathic Thrombophilia [GAIT] Project) that included a genome-wide scan, we demonstrated that a common polymorphism (46 C-->T) in the exon 1 of the F12 gene jointly influences variability of plasma Factor XII levels and susceptibility to thrombotic disease. We have investigated the risk of IS related to this polymorphism in a case-control study.
METHODS: We studied 436 individuals: 205 diagnosed with IS and 231 age-gender-ethnic control subjects. We measured Factor VIIIc, fibrinogen, and Factor XIIc levels, and we genotyped the 46 C-->T polymorphism in the F12 gene.
RESULTS: There were 91 women and 114 men in the IS group and 109 women and 122 men in the control group. We confirmed our previous observation that individuals with different genotypes for the 46 C-->T polymorphism showed significant differences in Factor XIIc levels. Most importantly, the mutated T allele in the homozygous state (genotype T/T) was associated with an increased risk of IS with an adjusted odds ratio of 4.1 (95% CI, 1.1 to 15.9).
CONCLUSIONS: This study suggests that the 46 C-->T polymorphism is a genetic risk factor for IS in the Spanish population. In addition, our results confirm that the use of genetic linkage studies along with a case-control association study is an extremely valuable approach for identifying DNA variants that affect complex diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232129     DOI: 10.1161/01.STR.0000133127.68041.a3

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time.

Authors:  Lorna M Houlihan; Gail Davies; Albert Tenesa; Sarah E Harris; Michelle Luciano; Alan J Gow; Kevin A McGhee; David C Liewald; David J Porteous; John M Starr; Gordon D Lowe; Peter M Visscher; Ian J Deary
Journal:  Am J Hum Genet       Date:  2010-03-18       Impact factor: 11.025

2.  Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.

Authors:  Francesc Calafell; Laura Almasy; Maria Sabater-Lleal; Alfonso Buil; Carolina Mordillo; Anna Ramírez-Soriano; Martin Sikora; Juan Carlos Souto; John Blangero; Jordi Fontcuberta; José Manuel Soria
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

Review 3.  Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.

Authors:  Evi Stavrou; Alvin H Schmaier
Journal:  Thromb Res       Date:  2010-03       Impact factor: 3.944

4.  A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study.

Authors:  Lu-Chen Weng; Mary Cushman; James S Pankow; Saonli Basu; Eric Boerwinkle; Aaron R Folsom; Weihong Tang
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

5.  Combined cis-regulator elements as important mechanism affecting FXII plasma levels.

Authors:  Maria Sabater-Lleal; Miguel Chillón; Carolina Mordillo; Angel Martínez; Estel Gil; José Mateo; John Blangero; Laura Almasy; Jordi Fontcuberta; José Manuel Soria
Journal:  Thromb Res       Date:  2009-09-27       Impact factor: 3.944

6.  Multiplex assay for genetic testing of thrombophilia: a method for routine clinical care.

Authors:  Mónica López; Pilar Giraldo; Patricia Alvarez; R Cornudella; Miguel Pocoví; Antonio Martínez; Jordi Fontcuberta; José Manuel Soria
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

8.  Quantitative variability of 342 plasma proteins in a human twin population.

Authors:  Yansheng Liu; Alfonso Buil; Ben C Collins; Ludovic C J Gillet; Lorenz C Blum; Lin-Yang Cheng; Olga Vitek; Jeppe Mouritsen; Genevieve Lachance; Tim D Spector; Emmanouil T Dermitzakis; Ruedi Aebersold
Journal:  Mol Syst Biol       Date:  2015-02-04       Impact factor: 11.429

9.  Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients.

Authors:  Georgios Athanasiadis; Esther Esteban; Magdanela Gayà Vidal; Robert Carreras Torres; Raoudha Bahri; Pedro Moral
Journal:  BMC Res Notes       Date:  2009-07-31

10.  Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.

Authors:  Naoto Katakami; Mitsuyoshi Takahara; Hideaki Kaneto; Ikki Shimizu; Keizo Ohno; Fukashi Ishibashi; Takeshi Osonoi; Atsunori Kashiwagi; Ryuzo Kawamori; Iichiro Shimomura; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.